Are you a new member? Sign up now
Login area
| Sign up
close
DARZALEX - 400mg/20ml - 1
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01FC01 | BioTech | Daratumumab - 400mg/20ml | 8899/388 | 167016/1 | DARZALEX | 400mg/20ml | 1 | Injectable concentrate for solution | Infusion | Mersaco | Cilag AG | Switzerland | L.L | 2.44 | E2 | Janssen Cilag International NV | Belgium | 2/5/2024 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01FC01 | BioTech | Daratumumab - 400mg/20ml | 8899 | 167016/1 | DARZALEX | 400mg/20ml | 1 | Injectable concentrate for solution | Infusion | Mersaco | Cilag AG | Switzerland | 160,134,596 L.L | 2.44 | E2 | Janssen Cilag International NV | Belgium | 2/5/2024 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024